Partner Headlines - BIIB

  1. Regeneron Tops 3 Med Stocks Moving Big On Earnings

    IBD
  2. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD
  3. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD
  4. Which Big-Cap Stocks Are Defying Market Pressure?

    IBD
  5. Caution Continues In Options Market This Week

    Benzinga
  6. A Big Day For Biotech And It's Not Going So Well

    Benzinga
  7. Benzinga's Volume Movers

    Benzinga
  8. A Look Ahead: Biotech And Energy ETFs To Watch This Week

    Benzinga
  9. Benzinga's Top Downgrades

    Benzinga
  10. Biogen Enters Collaboration with the Parkinson's Institute and ...

    Benzinga
  11. Biotech Stocks Falling Broadly, Here's Why And How Much

    Benzinga
  12. Biogen Tumbles On Outlook

    IBD
  13. Biotech IPO Boom Gaining Thrust With NantKwest Debut

    IBD
  14. Biogen Hacks Guidance, Raising Questions About Future

    IBD
  15. Stocks Fall For Fourth Day On Global Growth Worries

    IBD
  16. Major Indexes Extend Losses; Sucampo Bucks Weakness

    IBD
  17. Mid-Day Market Update: U.S. Stocks Slide; Marketo Shares Surge ...

    Benzinga
  18. Market Update: Friday's Mid-Day Market Movers: Amazon Shocks ...

    Benzinga
  19. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD
  20. Stocks Lower Near Midday; LogMeIn Breaks Out

    IBD
  21. Biogen Plunges On Slashed Guidance; AbbVie Q2 Mixed

    IBD
  22. Mid-Morning Market Update: Markets Slightly Higher; Amazon Earnings ...

    Benzinga
  23. Stocks Open Mixed And Wild; Maxim, Visa, Amazon Spike

    IBD
  24. Morning Market Losers

    Benzinga
  25. Benzinga's Top #PreMarket Losers

    Benzinga
  26. US Stock Futures Edge Higher; Amazon Profit Beats Views

    Benzinga
  27. Biogen Posts Higher Q2 Earnings, But Sales Miss Views

    Benzinga
  28. Earnings Scheduled For July 24, 2015

    Benzinga
  29. 10 Must Watch Stocks for Today

    Benzinga
  30. Stocks Extend Losses; Amazon, Visa Headline After-Hours Action

    IBD
  31. Alzheimer's Data Diverge

    IBD
  32. Illumina Breaches Key Level On Q2 Sales Miss

    IBD
  33. Biogen, Lilly Alzheimer's Data Spark Street Debate

    IBD
  34. Are We Any Closer to Finding a Drug to Battle Alzheimer's?

    FoxBusiness
  35. Earnings Loom For Handful Of Top Big Cap 20 Stocks

    IBD
  36. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD
  37. Why Big Biotech Could Have Another Leg Up

    Benzinga
  38. Celgene Hits High As Street Applauds Receptos Buyout

    IBD
  39. Benzinga's Top Upgrades

    Benzinga
  40. Don't Count Out Top Biotechs — They Still Got Game

    IBD
  41. Stocks Up For Second Day; Netflix, Allegiant Jump

    IBD
  42. Biogen Loses R&D Head As Alzheimer's Drug Data Loom

    IBD
  43. Stocks Hold Gains; Alaska Air Flies Near Buy Point

    IBD
  44. Douglas Williams to Leave Biogen for Biotechnology Start-Up

    Benzinga
  45. Stocks: Strong Gains, Light Trade; Liberty Global, NXP Lead Nasdaq ...

    IBD
  46. Morning Market Losers

    Benzinga
  47. Benzinga's Volume Movers

    Benzinga
  48. Biogen, AGTC find genetic link

    IBD
  49. Mid-Afternoon Market Update: International Speedway Slips On ...

    Benzinga
  50. Mid-Day Market Update: US Stocks Down; Xoom Shares Jump On Acquisition ...

    Benzinga
  51. Thursday's Mid-Day Movers: Real Good Solar, Xoom, ConforMIS, ...

    Benzinga
  52. Biogen, AGTC Link Up To Develop Gene Therapy

    IBD
  53. Mid-Morning Market Update: Markets Edge Higher; Centene To Acquire ...

    Benzinga
  54. Benzinga's Volume Movers

    Benzinga
  55. Morning Market Gainers

    Benzinga
  56. Benzinga's Top #PreMarket Gainers

    Benzinga
  57. Juno, Celgene Lead 5 Top Biotechs Nearing Buy Point

    IBD
  58. Roche 'High Efficacy' MS Drug Succeeds In Trials

    IBD
  59. Perrigo Going Up With Or Without Mylan, Says BMO

    IBD
  60. Biogen Phase 3 Study Of Aducanumab

    Benzinga
  61. Health Care Stocks Power S&P 500 To Q1 Earnings Beat

    IBD
  62. Stocks Stay In The Red, But IPOs FitBit, Fogo Score Big Gains

    IBD
  63. Fitbit Keeps Up Pace As Stocks Remain Near Session Highs

    IBD
  64. Big Biotech Stocks See Declining Short Interest

    Benzinga
  65. Isis rises on drug's results

    IBD
  66. Isis, Biogen Rare-Disease Drug Aids Infant Survival

    IBD
  67. Meet 8 Hot Med Stocks Among IBD's Big Cap Leaders

    IBD
  68. Health Care Mutual Funds Top In May: Close Look At Two Winners

    IBD
  69. Investment Strategies for the Bullish Biotech Sector

    GuruFocus
  70. Apple, SunEdison and Biogen: Hellman, Jordan Management's Top ...

    GuruFocus
  71. PRIMECAP Sells Portions of Its Top Two Stakes

    GuruFocus
  72. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD
  73. 5 NASDAQ Healthcare Stocks With The Highest EPS

    Benzinga
  74. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD
  75. China ETFs Power Ahead In 2015; Gold, Silver Get Shine Back

    IBD
  76. 3 Biotech Stocks See Growing Short Interest

    Benzinga
  77. Q1 Earnings Drive Industry Group Winners And Losers

    IBD
  78. SolarEdge Shares, Up 15%, Lead Techs' Late Rise

    IBD
  79. BIOGEN

    IBD
  80. Frothy China Or No, World Mutual Funds Topped In April

    IBD
  81. Isis Pharma Up As Bayer Licenses Thrombosis Drug

    IBD
  82. Biogen Making A Breakthrough In Treating Alzheimer's

    GuruFocus
  83. Growth Names Pressured As IBD 50 Slumps 4% For Week

    IBD
  84. Vanguard Healthcare Fund Adds Four New Positions

    GuruFocus
  85. Top-Rated Biotech Unravels Base-Building Effort

    IBD
  86. Biogen or Bluebird: Which Will Lead in SCD?

    GuruFocus
  87. Indexes Lower, Near Session Lows As Fed Announcement Nears

    IBD
  88. Biogen Continues To Decline After Friday's Rout

    Benzinga
  89. Biogen Misses On Tecfidera

    IBD
  90. With Market Back In Uptrend, IBD 50 Growth Names Thrive

    IBD
  91. Stocks Finish Solid Week; Akorn Restates 2014 Revenue

    IBD
  92. Biogen Shares Not Too Healthy After Q1 Miss

    Benzinga
  93. Chips Fall, But Nasdaq Holds Up; Avago Slices 50-Day Line

    IBD
  94. Stocks Firm Up As Amazon, Starbucks Gap To New Highs

    IBD
  95. Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives

    IBD
  96. Biogen Q1 Misses Estimates As Tecfidera Stalls

    IBD
  97. Biogen Misses Q1 Estimates, Shares Slide

    Benzinga
  98. Must Watch Stocks for April 24, 2015

    Benzinga
  99. Earnings Scheduled For April 24, 2015

    Benzinga
  100. Biogen Earnings Preview: What To Look For

    IBD
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!